These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19903442

  • 21. ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancer.
    Buzdar AU, Jonat W, Howell A, Plourde PV.
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):145-9. PubMed ID: 9365184
    [Abstract] [Full Text] [Related]

  • 22. Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data.
    Buzdar AU, Cuzick J.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 2):1037s-1048s. PubMed ID: 16467122
    [Abstract] [Full Text] [Related]

  • 23. Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer.
    Prescrire Int; 2001 Jun 01; 10(53):76-7. PubMed ID: 11718168
    [Abstract] [Full Text] [Related]

  • 24. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
    Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T, ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group.
    Cancer; 2003 Nov 01; 98(9):1802-10. PubMed ID: 14584060
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS, El-Hajj II, Makarem JA, Otrock ZK.
    Anticancer Drugs; 2006 Sep 01; 17(8):999-1002. PubMed ID: 16940812
    [Abstract] [Full Text] [Related]

  • 31. Anastrozole as neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer.
    Milla-Santos A, Milla L, Calvo N, Portella J, Rallo L, Casanovas JM, Pons M, Rodes J.
    Anticancer Res; 2004 Sep 01; 24(2C):1315-8. PubMed ID: 15154667
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR, Stuart M, Sahmoud T, Dixon JM.
    Br J Cancer; 2002 Oct 21; 87(9):950-5. PubMed ID: 12434282
    [Abstract] [Full Text] [Related]

  • 35. Grover disease (transient acantholytic dermatosis) induced by anastrozole.
    Crockett JS, Burkemper NM.
    Cutis; 2011 Oct 21; 88(4):175-7. PubMed ID: 22106724
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anastrozole-related acute hepatitis with autoimmune features: a case report.
    Inno A, Basso M, Vecchio FM, Marsico VA, Cerchiaro E, D'Argento E, Bagalà C, Barone C.
    BMC Gastroenterol; 2011 Mar 31; 11():32. PubMed ID: 21453541
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.